94 related articles for article (PubMed ID: 8694361)
21. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
24. Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception.
Buritova J; Chapman V; Honoré P; Besson JM
Eur J Pharmacol; 1996 May; 303(1-2):91-100. PubMed ID: 8804916
[TBL] [Abstract][Full Text] [Related]
25. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
26. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
Hammond DL; Presley R; Gogas KR; Basbaum AI
J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
[TBL] [Abstract][Full Text] [Related]
27. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
28. The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons.
Buritova J; Tarayre JP; Besson JM; Colpaert F
Brain Res; 2003 Jun; 974(1-2):212-21. PubMed ID: 12742639
[TBL] [Abstract][Full Text] [Related]
29. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
Le Guen S; Noble F; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Eur J Pharmacol; 2002 Apr; 441(3):141-50. PubMed ID: 12063085
[TBL] [Abstract][Full Text] [Related]
30. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation.
Honoré P; Buritova J; Besson JM
Pain; 1995 Dec; 63(3):365-375. PubMed ID: 8719538
[TBL] [Abstract][Full Text] [Related]
31. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Christensen D; Gautron M; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
[TBL] [Abstract][Full Text] [Related]
32. Fos expression in rat spinal cord induced by peripheral injection of BmK I, an alpha-like scorpion neurotoxin.
Bai ZT; Zhang XY; Ji YH
Toxicol Appl Pharmacol; 2003 Oct; 192(1):78-85. PubMed ID: 14554105
[TBL] [Abstract][Full Text] [Related]
33. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
Dunbar S; Yaksh TL
Anesthesiology; 1996 May; 84(5):1177-88. PubMed ID: 8624012
[TBL] [Abstract][Full Text] [Related]
34. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
35. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
Buritova J; Besson JM
Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
[TBL] [Abstract][Full Text] [Related]
36. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Honoré P; Buritova J; Chapman V; Besson JM
Pain; 1998 Apr; 75(2-3):281-93. PubMed ID: 9583764
[TBL] [Abstract][Full Text] [Related]
37. N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord.
Song B; Marvizón JC
Neuroscience; 2005; 136(2):549-62. PubMed ID: 16203108
[TBL] [Abstract][Full Text] [Related]
38. Contribution of peripheral N-methyl-D-aspartate receptors to c-fos expression in the trigeminal spinal nucleus following acute masseteric inflammation.
Ro JY; Capra NF; Masri R
Neuroscience; 2004; 123(1):213-9. PubMed ID: 14667456
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of c-Fos expression in the rat lumbosacral spinal cord by morphine or tramadol following noxious colorectal distention.
Traub RJ; Stitt S; Gebhart GF
Brain Res; 1995 Dec; 701(1-2):175-82. PubMed ID: 8925281
[TBL] [Abstract][Full Text] [Related]
40. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]